Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

Real-time Quote. Real-time Tradegate - 01/20 10:00:36 pm
63.289 EUR   -0.46%
01/19 UCB : files BRIVIACT® (brivaracetam) CV in the U.S. as …
01/19 UCB : Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary..
01/18 UCB : Transparency notification
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

UCB : marks World Parkinson’s Disease Day with new ‘Parkinson’s Well-Being Map™’

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/11/2012 | 07:34am CET

• The Parkinson's Well-Being Map™ is a new visual tool to support communication of a person's Parkinson's status with their healthcare team
• 'Living with Parkinson's Disease: Insights and Inspirations' video shares personal and motivational perspectives on PD

Brussels, Belgium, 11th April 2012, 0700 CET - UCB is announcing a new initiative for World Parkinson's Disease Day 2012 that is designed to support communication around all aspects of Parkinson's Disease (PD). The Parkinson's Well-Being Map™ is a visual tool designed to help people with PD discuss their health status and well-being with their care teams. A new video 'Living with Parkinson's Disease: Insights and Inspirations' is also shared today and gives a voice to people with Parkinson's on the effects of the condition on their lives.

The Parkinson's Well-Being Map™ was developed by UCB in consultation with people living with PD and in partnership with the European Parkinson's Disease Association (EPDA), the Cure Parkinson's Trust and the Spanish Federation of Parkinson's Disease.

"The Parkinson's Well-Being Map™ translates a complex issue into an 'at-a-glance' summary of symptoms of an individual's Parkinson's. By including both movement related and underlying symptoms, it can help people talk to their healthcare team about all aspects of Parkinson's including symptoms such as sleep disturbances and mood changes, which they may not have realised could be part of their Parkinson's," said Knut-Johan Onarheim, President of the EPDA.

Designed to be simple and easy to use, the Parkinson's Well-Being Map™ should help people with Parkinson's monitor and record their symptoms over time as well as summarise their health and well-being in preparation for their consultation with their healthcare team. The Map is already available in paper format in certain countries worldwide, and will be available in further countries during 2012.

UCB is committed to supporting educational programs that inspire and encourage people living with Parkinson's Disease to achieve their personal goals and to support communication on their health and well-being with their care team. The Parkinson's Well-Being Map™ builds on 'Today I will…' an ongoing initiative from UCB which encourages people affected by Parkinson's to make motivational pledges to inspire and support others.

'Today I will…' pledges received to date include:

• "Today I will… take inspiration from other pledges, then hopefully realise I'm not alone. I thank you all."
• "Today I will… totally forget my Parkinson's when walking in the sun, the energy comes back, the winter time is over and then I really enjoy my life!"
• "Today I will… ask my patient how they are living rather than how they are moving."

"Parkinson's Disease is a complicated condition which can have a significant impact on how people live their lives. At UCB we are committed to supporting people with Parkinson's by developing resources that help them to communicate their full range of symptoms to their healthcare teams and connect with each other for motivation and inspiration," said Lode Dewulf, MD, Vice President, Global Medical Affairs, UCB.

People can show their support on World Parkinson's Disease Day by viewing 'Living with Parkinson's Disease: Insights and Inspirations' at http://www.youtube.com/user/UCB?ob=0&feature=results_main or to learn more about UCB's educational initiatives to inspire people with Parkinson's including the Parkinson's Well-Being Map™ and 'Today I will…' visit www.parkinsons-voices.eu.

For further information
Eimear O Brien, Director, Communications, UCB
T +32.2.559.9271, eimear.obrien@ucb.com

NOTES TO EDITORS

About World Parkinson's Disease Day
World Parkinson's Disease Day is marked on April 11 in commemoration of the birth of Dr. James Parkinson (1755 - 1824) who established the disease as a clinical entity.1 Activities on this day aim to raise public awareness for one of the most common progressive degenerative neurological disorders and to show support for people living with the condition.

About Parkinson's Voices ( )
Parkinson's Voices (www.parkinsons-voices.eu) is a UCB website created for people who want to know more about PD, to share experiences with those who have the condition, and to find out how different members of their healthcare team can help them. www.parkinsons-voices.eu

About Parkinson's Disease
PD is a progressive neurological condition which affects over six million people worldwide.2 It is predominantly characterised by problems with body movements, known as 'motor symotoms'.2 The classical symptoms of PD are tremor, muscular rigidity and bradykinesia including slowness and poverty of movement.3 Other underlying symptoms that are not related to movement can also occur such as pain, sleep disturbance and mood changes.2

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

References
1. European Parkinson's Disease Association Charter. 1997. Available at http://www.epda.eu.com/worldpdday/epda-charter/ Last accessed March 2012
2. European Parkinson's Disease Association - Life with Parkinson's disease: What is Parkinson's disease? Available at: http://www.parkinsonsawareness.eu.com/en/campaign-literature/what-is-parkinsons-disease/ Last accessed March 2012
3. European Parkinson's Disease Association - Life with Parkinson's disease: Symptoms Available at: http://www.parkinsonsawareness.eu. Last accessed March 2012

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on UCB
01/19 UCB : files BRIVIACT® (brivaracetam) CV in the U.S. as …
01/19 UCB : Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy &h..
01/18 UCB : Transparency notification
01/18 UCB : Transparency notification
01/18 UCB : Transparency Notification
01/18 UCB : Transparency notification
01/18 UCB : Transparency notification
01/18 UCB : Transparency notification
01/06 Lori Lyons-Williams Joins Dermira as Chief Commercial Officer
01/05 DERMIRA : Elects Emmanuel Caeymaex to Board of Directors
More news
Sector news : Pharmaceuticals - NEC
09:21p European shares ease ahead of Trump inauguration
06:20p Bristol-Myers shares fall on lung cancer timeline setback
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/19 Davos CEOs 'go local' on supply chain in Trump era
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/10 RHEUMATOID ARTHRITIS : The Big 3 And The Future
2016 Marketing application filed in Japan for osteoporosis candidate romosozumab
2016 Late-stage study shows Amgen and UCB's romosozumab significantly increases bo..
2016 AMGEN GETS BUSY; MANY NEWS ITEMS : Anything Good Yet?
2016 UCB S.A. 2016 Q1 - Results - Earnings Call Slides
Advertisement
Financials (€)
Sales 2016 4 058 M
EBIT 2016 749 M
Net income 2016 472 M
Debt 2016 910 M
Yield 2016 1,91%
P/E ratio 2016 24,34
P/E ratio 2017 19,76
EV / Sales 2016 3,27x
EV / Sales 2017 2,99x
Capitalization 12 367 M
More Financials
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Technical analysis trends UCB
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 76,7 €
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jean-Christophe Tellier Chief Executive Officer & Executive Director
Gerhard N. Mayr Chairman
Mark D. McDade Chief Operating Officer & Executive Vice President
Detlef Thielgen Chief Financial Officer & Executive Vice President
Iris Loew-Friedrich Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
UCB5.84%13 202
JOHNSON & JOHNSON-0.88%310 685
ROCHE HOLDING LTD.1.29%200 208
PFIZER INC.-2.40%192 367
NOVARTIS AG-3.71%185 489
MERCK & CO., INC.2.48%166 338
More Results